clinical cancer research table of contents...kam-weng fong, kiattisa sommat, yoke lim soong, ying...

4
SPECIAL FEATURES Highlights of This Issue 1771 Editorial 1773 Introducing a New Series: Immunotherapy Facts and Hopes Ignacio Melero, Mario Sznol, Marlowe S. Tessmer, Theresa L. Whiteside, and Jedd D. Wolchok CCR Translations 1775 Small-Cell Neuroendocrine Tumors: Cell State Trumps the Oncogenic Driver Matthew G. Oser and Pasi A. Janne See related article, p. 1965 1777 Harnessing the Power of Patient-Reported Outcomes in Oncology Ryan D. Nipp and Jennifer S. Temel See related article, p. 1780 CCR Perspectives in Regulatory Science and Policy 1780 Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections Janice Kim, Harpreet Singh, Kassa Ayalew, Kristina Borror, Michelle Campbell, Laura Lee Johnson, Alyson Karesh, Ni A. Khin, Joanne R. Less, Jerry Menikoff, Lori Minasian, Sandra A. Mitchell, Elektra J. Papadopoulos, Richard L. Piekarz, Kevin A. Prohaska, Susan Thompson, Rajeshwari Sridhara, Richard Pazdur, and Paul G. Kluetz See related commentary, p. 1777 Review 1785 Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors Denis L. Jardim, D ebora de Melo Gagliato, Francis J. Giles, and Razelle Kurzrock Perspectives 1795 Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? Sheheryar Kabraji, Jing Ni, Nancy U. Lin, Shaozhen Xie, Eric P. Winer, and Jean J. Zhao CANCER THERAPY: CLINICAL 1805 Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study Michael B. Atkins, F. Stephen Hodi, John A. Thompson, David F. McDermott, Wen-Jen Hwu, Donald P. Lawrence, Nancy A. Dawson, Deborah J. Wong, Shailender Bhatia, Marihella James, Lokesh Jain, Seth Robey, Xinxin Shu, Blanca Homet Moreno, Rodolfo F. Perini, Toni K. Choueiri, and Antoni Ribas 1816 Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer Neil H. Segal, Aiwu R. He, Toshihiko Doi, Ronald Levy, Shailender Bhatia, Michael J. Pishvaian, Rossano Cesari, Ying Chen, Craig B. Davis, Bo Huang, Aron D. Thall, and Ajay K. Gopal 1824 Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials Yu-Pei Chen, Ling-Long Tang, Qi Yang, Sharon-Shuxian Poh, Edwin P. Hui, Anthony T.C. Chan, Whee-Sze Ong, Terence Tan, Joseph Wee, Wen-Fei Li, Lei Chen, Brigette B.Y. Ma, Macy Tong, Sze-Huey Tan, Shie-Lee Cheah, Kam-Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Ying Guo, Ai-Hua Lin, Ying Sun, Ming-Huang Hong, Su-Mei Cao, Ming-Yuan Chen, and Jun Ma 1834 Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML Andreas T. Bjorklund, Mattias Carlsten, Ebba Sohlberg, Lisa L. Liu, Trevor Clancy, Mohsen Karimi, Sarah Cooley, Jeffrey S. Miller, Monika Klimkowska, Marie Schaffer, Emma Watz, Kristina Wikstrom, Pontus Blomberg, Bjorn Engelbrekt Wahlin, Marzia Palma, Lotta Hansson, Per Ljungman, Eva Hellstrom-Lindberg, Hans-Gustaf Ljunggren, and Karl-Johan Malmberg 1845 Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification Isabel Echavarria, Sara L opez-Tarruella, Antoni Picornell, Jose Angel García-Saenz, Yolanda Jerez, Katherine Hoadley, Henry L. G omez, Fernando Moreno, María Del Monte-Millan, Iv an M arquez-Rodas, Enrique Alvarez, Rocío Ramos-Medina, Javier Gayarre, Tatiana Massarrah, Inmaculada Oca~ na, María Cebollero, Hugo Fuentes, Agusti Barnadas, Ana Isabel Ballesteros, Uriel Bohn, Charles M. Perou, and Miguel Martin April 15, 2018 Volume 24 Number 8 Clinical Cancer Research Table of Contents vi on April 7, 2021. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from

Upload: others

Post on 24-Oct-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

  • SPECIAL FEATURES

    Highlights of This Issue 1771

    Editorial

    1773 Introducing a New Series: Immunotherapy Factsand HopesIgnacio Melero, Mario Sznol, Marlowe S. Tessmer,Theresa L. Whiteside, and Jedd D. Wolchok

    CCR Translations

    1775 Small-Cell Neuroendocrine Tumors: Cell StateTrumps the Oncogenic DriverMatthew G. Oser and Pasi A. J€anneSee related article, p. 1965

    1777 Harnessing the Power of Patient-ReportedOutcomes in OncologyRyan D. Nipp and Jennifer S. TemelSee related article, p. 1780

    CCR Perspectives in Regulatory Scienceand Policy

    1780 Use of PRO Measures to Inform Tolerability inOncology Trials: Implications for Clinical Review,IND Safety Reporting, and Clinical SiteInspectionsJanice Kim, Harpreet Singh, Kassa Ayalew, Kristina Borror,Michelle Campbell, Laura Lee Johnson, Alyson Karesh,Ni A. Khin, Joanne R. Less, Jerry Menikoff, Lori Minasian,Sandra A. Mitchell, Elektra J. Papadopoulos,Richard L. Piekarz, Kevin A. Prohaska, Susan Thompson,Rajeshwari Sridhara, Richard Pazdur, and Paul G. KluetzSee related commentary, p. 1777

    Review

    1785 Analysis of Drug Development Paradigms forImmune Checkpoint InhibitorsDenis L. Jardim, D�ebora de Melo Gagliato, Francis J. Giles,and Razelle Kurzrock

    Perspectives

    1795 Drug Resistance in HER2-Positive Breast CancerBrain Metastases: Blame the Barrier or the Brain?Sheheryar Kabraji, Jing Ni, Nancy U. Lin, Shaozhen Xie,Eric P. Winer, and Jean J. Zhao

    CANCER THERAPY: CLINICAL

    1805 Pembrolizumab Plus Pegylated Interferon alfa-2bor Ipilimumab for Advanced Melanoma or RenalCell Carcinoma: Dose-Finding Results from thePhase Ib KEYNOTE-029 StudyMichael B. Atkins, F. Stephen Hodi, John A. Thompson,David F. McDermott, Wen-Jen Hwu, Donald P. Lawrence,Nancy A. Dawson, Deborah J. Wong, Shailender Bhatia,Marihella James, Lokesh Jain, Seth Robey, Xinxin Shu,Blanca Homet Moreno, Rodolfo F. Perini, Toni K. Choueiri,and Antoni Ribas

    1816 Phase I Study of Single-Agent Utomilumab(PF-05082566), a 4-1BB/CD137 Agonist, inPatients with Advanced CancerNeil H. Segal, Aiwu R. He, Toshihiko Doi, Ronald Levy,Shailender Bhatia, Michael J. Pishvaian, Rossano Cesari,Ying Chen, Craig B. Davis, Bo Huang, Aron D. Thall, andAjay K. Gopal

    1824 Induction Chemotherapy plus ConcurrentChemoradiotherapy in Endemic NasopharyngealCarcinoma: Individual Patient Data PooledAnalysis of Four Randomized TrialsYu-Pei Chen, Ling-Long Tang,Qi Yang, Sharon-Shuxian Poh,Edwin P. Hui, Anthony T.C. Chan, Whee-Sze Ong,Terence Tan, Joseph Wee, Wen-Fei Li, Lei Chen,Brigette B.Y. Ma, Macy Tong, Sze-Huey Tan, Shie-Lee Cheah,Kam-Weng Fong, Kiattisa Sommat, Yoke Lim Soong,Ying Guo, Ai-Hua Lin, Ying Sun, Ming-Huang Hong,Su-Mei Cao, Ming-Yuan Chen, and Jun Ma

    1834 Complete Remission with Reduction of High-RiskClones following Haploidentical NK-Cell Therapyagainst MDS and AMLAndreas T. Bj€orklund, Mattias Carlsten, Ebba Sohlberg,Lisa L. Liu, Trevor Clancy, Mohsen Karimi, Sarah Cooley,Jeffrey S. Miller, Monika Klimkowska, Marie Schaffer,Emma Watz, Kristina Wikstr€om, Pontus Blomberg,Bj€orn Engelbrekt Wahlin, Marzia Palma, Lotta Hansson,Per Ljungman, Eva Hellstr€om-Lindberg,Hans-Gustaf Ljunggren, and Karl-Johan Malmberg

    1845 Pathological Response in a Triple-Negative BreastCancer Cohort Treated with NeoadjuvantCarboplatin and Docetaxel According toLehmann's Refined ClassificationIsabel Echavarria, Sara L�opez-Tarruella, Antoni Picornell,

    Jose �Angel García-Saenz, Yolanda Jerez, Katherine Hoadley,HenryL.G�omez, FernandoMoreno,MaríaDelMonte-Millan,Iv�anM�arquez-Rodas, Enrique Alvarez, Rocío Ramos-Medina,Javier Gayarre, Tatiana Massarrah, Inmaculada Oca~na,María Cebollero, Hugo Fuentes, Agusti Barnadas,Ana Isabel Ballesteros, Uriel Bohn, Charles M. Perou, andMiguel Martin

    April 15, 2018 � Volume 24 � Number 8

    Clinical Cancer Research

    Table ofContents

    vi

    on April 7, 2021. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from

    http://clincancerres.aacrjournals.org/

  • PERSONALIZED MEDICINE AND IMAGING

    1853 HER3-Mediated Resistance to Hsp90 InhibitionDetected in Breast Cancer Xenografts byAffibody-Based PET ImagingCarlos D. Martins, Chiara Da Pieve, Thomas A. Burley,Rhodri Smith, Daniela M. Ciobota, Louis Allott,Kevin J. Harrington, Wim J.G. Oyen, Graham Smith, andGabriela Kramer-Marek

    1866 Further Investigation of the Role of ACYP2 andWFS1 Pharmacogenomic Variants in theDevelopment of Cisplatin-Induced Ototoxicity inTesticular Cancer PatientsBritt I. Dr€ogem€oller, Beth Brooks, Carol Critchley,Jos�e G. Monzon, Galen E.B. Wright, Geoffrey Liu,Daniel J. Renouf, Christian K. Kollmannsberger,Philippe L. Bedard, Michael R. Hayden, Karen A. Gelmon,Bruce C. Carleton, and Colin J.D. Ross

    1872 Early Assessment of Lung Cancer ImmunotherapyResponse via Circulating Tumor DNASarah B. Goldberg, Azeet Narayan, Adam J. Kole,Roy H. Decker, Jimmitti Teysir, Nicholas J. Carriero,Angela Lee, Roxanne Nemati, Sameer K. Nath,Shrikant M. Mane, Yanhong Deng, Nitin Sukumar,Daniel Zelterman, Daniel J. Boffa, Katerina Politi,Scott N. Gettinger, Lynn D. Wilson, Roy S. Herbst, andAbhijit A. Patel

    1881 Hybrid Capture–Based Genomic Profilingof Circulating Tumor DNA from Patients withAdvanced Cancers of the GastrointestinalTract or AnusAlexa B. Schrock, Dean Pavlick, Samuel J. Klempner,JonH. Chung, Brady Forcier, AllisonWelsh, Lauren Young,Bryan Leyland-Jones, Rodolfo Bordoni,Richard D. Carvajal, Joseph Chao, Razelle Kurzrock,Jason K. Sicklick, Jeffrey S. Ross, Philip J. Stephens,Craig Devoe, Fadi Braiteh, Siraj M. Ali, andVincent A. Miller

    CANCER THERAPY: PRECLINICAL

    1891 Nitric Oxide Production by Myeloid-DerivedSuppressor Cells Plays a Role in Impairing FcReceptor–Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse,Elizabeth McMichael, Thomas A. Mace, Brooke Benner,Kari Kendra, Amanda Campbell, Shalini Gautam,David Abood, Ian Landi, Vincent Hsu, Megan Duggan,Robert Wesolowski, Matthew Old, John Harrison Howard,Lianbo Yu, Nancy Stasik, Thomas Olencki,Natarajan Muthusamy, Susheela Tridandapani,John C. Byrd, Michael Caligiuri, and William E. Carson

    1905 A Combination of SAHA and Quinacrine IsEffective in Inducing Cancer Cell Death in UpperGastrointestinal CancersShoumin Zhu, Zheng Chen, Lihong Wang, Dunfa Peng,Abbes Belkhiri, A. Craig Lockhart, and Wael El-Rifai

    1917 STAT5A/B Blockade Sensitizes Prostate Cancerto Radiation through Inhibition of RAD51 andDNA RepairCristina Maranto, Vindhya Udhane, David T. Hoang,Lei Gu, Vitali Alexeev, Kareem Malas, Karmel Cardenas,Jonathan R. Brody, Ulrich Rodeck, Carmen Bergom,Ken A. Iczkowski, Ken Jacobsohn, William See,Sara M. Schmitt, and Marja T. Nevalainen

    1932 Ponatinib Shows Potent Antitumor Activity inSmall Cell Carcinoma of the OvaryHypercalcemic Type (SCCOHT) throughMultikinase InhibitionJessica D. Lang, William P.D. Hendricks,Krystal A. Orlando, Hongwei Yin, Jeffrey Kiefer,Pilar Ramos, Ritin Sharma, Patrick Pirrotte,Elizabeth A. Raupach, Chris Sereduk, Nanyun Tang,Winnie S. Liang, Megan Washington, Salvatore J. Facista,Victoria L. Zismann, Emily M. Cousins, Michael B. Major,Yemin Wang, Anthony N. Karnezis, Aleksandar Sekulic,Ralf Hass, Barbara C. Vanderhyden, Praveen Nair,Bernard E. Weissman, David G. Huntsman, andJeffrey M. Trent

    1944 Overcoming Resistance to DNA-Targeted Agentsby Epigenetic Activation of Schlafen 11 (SLFN11)Expression with Class I Histone DeacetylaseInhibitorsSai-Wen Tang, Anish Thomas, JunkoMurai, Jane B. Trepel,Susan E. Bates, Vinodh N. Rajapakse, and Yves Pommier

    BIOLOGY OF HUMAN TUMORS

    1954 Wide Expression and Significance of AlternativeImmune Checkpoint Molecules, B7x and HHLA2,in PD-L1–Negative Human Lung CancersHaiying Cheng, Alain Borczuk, Murali Janakiram,Xiaoxin Ren, Juan Lin, Amer Assal, Balazs Halmos,Roman Perez-Soler, and Xingxing Zang

    1965 Small-Cell Carcinomas of the Bladder and LungAre Characterized by a Convergent but DistinctPathogenesisMatthew T. Chang, Alexander Penson, Neil B. Desai,Nicholas D. Socci, Ronglai Shen, Venkatraman E. Seshan,Ritika Kundra, Adam Abeshouse, Agnes Viale,Eugene K. Cha, Xueli Hao, Victor E. Reuter,Charles M. Rudin, Bernard H. Bochner,Jonathan E. Rosenberg, Dean F. Bajorin, Nikolaus Schultz,Michael F. Berger, Gopa Iyer, David B. Solit,Hikmat A. Al-Ahmadie, and Barry S. TaylorSee related commentary, p. 1775

    Table of Contents

    vii

    on April 7, 2021. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from

    http://clincancerres.aacrjournals.org/

  • 1974 PBX3 Is Part of an EMT Regulatory Network andIndicates Poor Outcome in Colorectal CancerSebastian Lamprecht, Markus Kaller, Eva Marina Schmidt,Cristina Blaj, Tobias S. Schiergens, Jutta Engel,Andreas Jung, Heiko Hermeking,Thomas G.P. Gr€unewald, Thomas Kirchner, andDavid Horst

    1987 Reactivation of cAMP Pathway by PDE4DInhibition Represents a Novel Druggable Axis forOvercoming Tamoxifen Resistance in ER-positiveBreast CancerRasmi R. Mishra, Nevin Belder, Suhail A. Ansari,Merve Kayhan, Hilal Bal, Umar Raza, Pelin G. Ersan,

    Ünal M. Tokat, Erol Ey€upo�glu, €Ozge Saatci,Pouria Jandaghi, Stefan Wiemann, Ayşeg€ul Üner,

    Caglar Cekic, Yasser Riazalhosseini, and €Ozg€ur Şahin

    2002 Long Noncoding RNA LINC01234 Functions as aCompeting Endogenous RNA to Regulate CBFBExpression by Sponging miR-204-5p in GastricCancerXin Chen, Zhenyao Chen, Shanxun Yu, Fengqi Nie,Shuai Yan, Pei Ma, Qinnan Chen, Chenchen Wei,Hangjiang Fu, Tianwei Xu, Shengnan Ren, Ming Sun, andZhaoxia Wang

    2015 REGg Controls Hippo Signaling and ReciprocalNF-kB–YAP Regulation to Promote Colon CancerQingwei Wang, Xiao Gao, Tong Yu, Lei Yuan, Jie Dai,Weicang Wang, Geng Chen, Chan Jiao, Wang Zhou,Quan Huang, Long Cui, Pei Zhang, Robb E. Moses,Jianhua Yang, Fengyuan Chen, Junjiang Fu, Jianru Xiao,Lei Li, Yongyan Dang, and Xiaotao Li

    AC icon indicates AuthorChoice

    For more information please visit www.aacrjournals.org

    ABOUT THE COVER

    The cover shows a mixed urothelial and small cell carcinoma from a single patient. Deepsequencing of macrodissected urothelial and small-cell components revealed truncalmutations clonal in both components, indicating a common ancestral origin. Other drivermutations were clonal exclusively in one component. For details, see the article by Changand colleagues on page 1965 of this issue.

    Table of Contents

    viii

    on April 7, 2021. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from

    http://clincancerres.aacrjournals.org/

  • 2018;24:1771-2025. Clin Cancer Res 24 (8)

    Updated version

    http://clincancerres.aacrjournals.org/content/24/8

    Access the most recent version of this article at:

    E-mail alerts related to this article or journal.Sign up to receive free email-alerts

    Subscriptions

    Reprints and

    [email protected]

    To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at

    Permissions

    Rightslink site. Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC)

    .http://clincancerres.aacrjournals.org/content/24/8To request permission to re-use all or part of this article, use this link

    on April 7, 2021. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from

    http://clincancerres.aacrjournals.org/content/24/8http://clincancerres.aacrjournals.org/cgi/alertsmailto:[email protected]://clincancerres.aacrjournals.org/content/24/8http://clincancerres.aacrjournals.org/

    /ColorImageDict > /JPEG2000ColorACSImageDict > /JPEG2000ColorImageDict > /AntiAliasGrayImages false /CropGrayImages false /GrayImageMinResolution 200 /GrayImageMinResolutionPolicy /Warning /DownsampleGrayImages true /GrayImageDownsampleType /Bicubic /GrayImageResolution 300 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50000 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages true /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict > /GrayImageDict > /JPEG2000GrayACSImageDict > /JPEG2000GrayImageDict > /AntiAliasMonoImages false /CropMonoImages false /MonoImageMinResolution 600 /MonoImageMinResolutionPolicy /Warning /DownsampleMonoImages true /MonoImageDownsampleType /Bicubic /MonoImageResolution 900 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict > /AllowPSXObjects false /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile (None) /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False

    /CreateJDFFile false /Description > /Namespace [ (Adobe) (Common) (1.0) ] /OtherNamespaces [ > /FormElements false /GenerateStructure false /IncludeBookmarks false /IncludeHyperlinks false /IncludeInteractive false /IncludeLayers false /IncludeProfiles false /MarksOffset 18 /MarksWeight 0.250000 /MultimediaHandling /UseObjectSettings /Namespace [ (Adobe) (CreativeSuite) (2.0) ] /PDFXOutputIntentProfileSelector /NA /PageMarksFile /RomanDefault /PreserveEditing true /UntaggedCMYKHandling /LeaveUntagged /UntaggedRGBHandling /LeaveUntagged /UseDocumentBleed false >> > ]>> setdistillerparams> setpagedevice